Feed Preview

Angiogenesis Inhibitors to Treat Cancer

Angiogenesis Inhibitors to Treat Cancer diagram by undefined

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Top 20 most recent papers
bioRxiv

Cancer Associated Fibroblasts Mediate Cancer Progression and Remodel the Tumouroid Stroma

bioRxivNovember 29, 2019
Judith PapeUmber Cheema
10
bioRxiv

Osteoblast-osteoclast co-culture amplifies inhibitory effects of FG-4592 on osteoclast formation and reduces bone resorption activity

bioRxivDecember 5, 2019
Philippa A HulleyHelen J Knowles
1
bioRxiv

The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype

bioRxivNovember 29, 2019
Alejandro Javier EspañolMaría Elena Sales
Chemical Science

Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples

Chemical ScienceSeptember 28, 2019
Marcin PorebaGuy S Salvesen
Oncogene

PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis

OncogeneDecember 4, 2019
Tao QianYing Ying Sun
Molecular Cancer

Harnessing tumor-associated macrophages as aids for cancer immunotherapy

Molecular CancerDecember 5, 2019
Xiao-Lei LiYu-Fang Shi
Oncogene

Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target

OncogeneDecember 4, 2019
Panagiota S FilippouAnastasia Constantinidou
Carcinogenesis

Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer

CarcinogenesisDecember 5, 2019
Aya Naiki-ItoSatoru Takahashi
2
1
Life Sciences

Therapeutic potentials of Apatinib in cancer treatment: Possible mechanisms and clinical relevance

Life SciencesNovember 28, 2019
Nazila Fathi MaroufiMohammad Nouri
Journal for Immunotherapy of Cancer

Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions

Journal for Immunotherapy of CancerNovember 29, 2019
Marc HilmiBenoît Rousseau
4
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry

Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids

Molecules : a Journal of Synthetic Chemistry and Natural Product ChemistryNovember 13, 2019
Rebecca BorellaMarcello Pinti
1
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry

Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine

Molecules : a Journal of Synthetic Chemistry and Natural Product ChemistryNovember 24, 2019
Mohammad Bagher MajnooniAnupam Bishayee
Journal of Virology

Kaposi's Sarcoma-associated Herpesvirus Viral Interleukin 6 Signaling Upregulates Integrin Beta 3 Levels and is Dependent on STAT3

Journal of VirologyDecember 4, 2019
Ricardo Rivera-SotoBlossom A Damania
Frontiers in Oncology

Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases

Frontiers in OncologyNovember 18, 2019
Olga KersyGuy Lahat
Cancer Cell International

Roles of sphingosine-1-phosphate signaling in cancer

Cancer Cell InternationalNovember 14, 2019
Peng WangXun Qi
OncoTargets and Therapy

Estrogen Receptor Beta Inhibits The Proliferation, Migration, And Angiogenesis Of Gastric Cancer Cells Through Inhibiting Nuclear Factor-Kappa B Signaling

OncoTargets and TherapyNovember 5, 2019
Yi-Ping ZhangLi-li Wang
Medicinal Chemistry

Structural modifications on CORM-3 lead to enhanced anti-angiogenic properties against triple-negative breast cancer cells

Medicinal ChemistryDecember 5, 2019
Malamati KourtiAndrew D. Westwell
Frontiers in Oncology

Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma

Frontiers in OncologyNovember 15, 2019
Yun-Soo SeoHae-June Lee
Oncology Letters

Differentiation and roles of bone marrow-derived cells on the tumor microenvironment of oral squamous cell carcinoma

Oncology LettersDecember 1, 2019
Chang AnqiHitoshi Nagatsuka
Journal of Controlled Release : Official Journal of the Controlled Release Society

Dual stimuli-guided lipid-based delivery system of cancer combination therapy

Journal of Controlled Release : Official Journal of the Controlled Release SocietyDecember 3, 2019
Te-I LiuHsin-Cheng Chiu

See more papers from this feed

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

© 2019 Meta ULC. All rights reserved
/feed-previews/angiogenesis-inhibitors-to-treat/91da804f-fb64-43c0-b5d5-7a6ecb289e43